Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous ketorolac + magnesium sulfate vs ketorolac + placebo for pain reduction in Colles' fracture
IRCT20120215009014N495Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Colles fracture comparing Ketorolac + magnesium sulfate with Ketorolac + placebo (2 arms). Primary endpoint: Pain reduction. Started Feb 2024; status: completed.
02
Drugs
ketorolacmagnesium sulfate
03
Conditions
Colles fracture
Beyond the preview
Go deeper on IRCT20120215009014N495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N495.